Literature DB >> 29364213

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells.

Jose Perdomo1, Feng Yan2, Halina H L Leung2, Beng H Chong3.   

Abstract

Platelet production occurs principally in the bone marrow in a process known as thrombopoiesis. During thrombopoiesis, hematopoietic progenitor cells differentiate to form platelet precursors called megakaryocytes, which terminally differentiate to release platelets from long cytoplasmic processes termed proplatelets. Megakaryocytes are rare cells confined to the bone marrow and are therefore difficult to harvest in sufficient numbers for laboratory use. Efficient production of human megakaryocytes can be achieved in vitro by culturing CD34+ cells under suitable conditions. The protocol detailed here describes isolation of CD34+ cells by magnetic cell sorting from umbilical cord blood samples. The necessary steps to produce highly pure, mature megakaryocytes under serum-free conditions are described. Details of phenotypic analysis of megakaryocyte differentiation and determination of proplatelet formation and platelet production are also provided. Effectors that influence megakaryocyte differentiation and/or proplatelet formation, such as anti-platelet antibodies or thrombopoietin mimetics, can be added to cultured cells to examine biological function.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29364213      PMCID: PMC5908394          DOI: 10.3791/56420

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage.

Authors:  Mi-Hyun Shim; Aubree Hoover; Noel Blake; Jonathan G Drachman; Jo Anna Reems
Journal:  Exp Hematol       Date:  2004-07       Impact factor: 3.084

2.  Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Authors:  Muna Iraqi; Jose Perdomo; Feng Yan; Philip Y-I Choi; Beng H Chong
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

3.  A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells.

Authors:  Manish J Gandhi; Jonathan G Drachman; Jo-Anna Reems; David Thorning; Brian J Lannutti
Journal:  Blood Cells Mol Dis       Date:  2005 Jul-Aug       Impact factor: 3.039

4.  Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.

Authors:  Paola R Lev; Matías Grodzielski; Nora P Goette; Ana C Glembotsky; Yesica R Espasandin; Marta S Pierdominici; Geraldine Contrufo; Verónica S Montero; Luciana Ferrari; Felisa C Molinas; Paula G Heller; Rosana F Marta
Journal:  Br J Haematol       Date:  2014-03-27       Impact factor: 6.998

5.  A unique population of CD34+ cells in cord blood.

Authors:  M T Nimgaonkar; R A Roscoe; J Persichetti; W B Rybka; A Winkelstein; E D Ball
Journal:  Stem Cells       Date:  1995-03       Impact factor: 6.277

Review 6.  In vitro megakaryocyte production and platelet biogenesis: state of the art.

Authors:  Jo-Anna Reems; Nicolas Pineault; Sijie Sun
Journal:  Transfus Med Rev       Date:  2010-01

Review 7.  Drug-induced immune thrombocytopenia.

Authors:  Beng H Chong; Philip Young-Ill Choi; Levon Khachigian; Jose Perdomo
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-09       Impact factor: 3.722

8.  In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells.

Authors:  F C Zeigler; F de Sauvage; H R Widmer; G A Keller; C Donahue; R D Schreiber; B Malloy; P Hass; D Eaton; W Matthews
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

9.  Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional.

Authors:  E S Choi; J L Nichol; M M Hokom; A C Hornkohl; P Hunt
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

10.  Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming.

Authors:  Thomas Moreau; Amanda L Evans; Louella Vasquez; Marloes R Tijssen; Ying Yan; Matthew W Trotter; Daniel Howard; Maria Colzani; Meera Arumugam; Wing Han Wu; Amanda Dalby; Riina Lampela; Guenaelle Bouet; Catherine M Hobbs; Dean C Pask; Holly Payne; Tatyana Ponomaryov; Alexander Brill; Nicole Soranzo; Willem H Ouwehand; Roger A Pedersen; Cedric Ghevaert
Journal:  Nat Commun       Date:  2016-04-07       Impact factor: 14.919

View more
  6 in total

1.  Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells.

Authors:  Aditi Bapat; Nakia Keita; Shalini Sharma
Journal:  J Vis Exp       Date:  2019-08-09       Impact factor: 1.355

2.  Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.

Authors:  José Perdomo; Halina H L Leung; Zohra Ahmadi; Feng Yan; James J H Chong; Freda H Passam; Beng H Chong
Journal:  Nat Commun       Date:  2019-03-21       Impact factor: 14.919

Review 3.  Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering.

Authors:  Constanca Figueiredo; Rainer Blasczyk
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561

4.  Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia.

Authors:  Halina H L Leung; Jose Perdomo; Zohra Ahmadi; Feng Yan; Steven E McKenzie; Beng H Chong
Journal:  Blood Adv       Date:  2021-12-14

5.  Augmented Production of Platelets From Cord Blood With Euchromatic Histone Lysine Methyltransferase Inhibition.

Authors:  Yiying Liu; Jingjing Zhao; Yan Wang; Pei Su; Hongtao Wang; Cuicui Liu; Jiaxi Zhou
Journal:  Stem Cells Transl Med       Date:  2022-09-21       Impact factor: 7.655

6.  ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genes.

Authors:  Marlie H Fisher; Gregory D Kirkpatrick; Brett Stevens; Courtney Jones; Michael Callaghan; Madhvi Rajpurkar; Joy Fulbright; Megan A Cooper; Jesse Rowley; Christopher C Porter; Arthur Gutierrez-Hartmann; Kenneth Jones; Craig Jordan; Eric M Pietras; Jorge Di Paola
Journal:  JCI Insight       Date:  2020-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.